Study details
Enrolling now
Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
Milton S. Hershey Medical Center
NCT IDNCT05998629ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 1.4 years
Ages
18–80
Locations
1 site in PA
About this study
This trial is testing a new device to diagnose cystic fibrosis (CF). The device measures sweat chloride levels using two channels. This single-center trial will enroll 30 participants, including adults with CF or healthy volunteers, and it will compare the device's measurements to standard lab tests.
Based on ClinicalTrials.gov records.
What participants do
- 1.Undergo Standard of Care laboratory procedure for measurement of sweat
- 2.Use a skin-interfaced colorimetric bifluidic sweat device with two synchronous channels
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Respiratory